Empirical Evaluation of Very Large Treatment Effects of Medical InterventionsPEREIRA, Tiago V; HORWITZ, Ralph I; IOANNIDIS, John P. A et al.JAMA, the journal of the American Medical Association. 2012, Vol 308, Num 16, pp 1676-1684, issn 0098-7484, 9 p.Article

HYPEREOSINOPHILIA RESPONDING TO EMPIRICAL ANTIHELMINTHIC TREATMENTLOH, Keng-Yin; LEE, Xin-Er.Southeast Asian journal of tropical medicine and public health. 2010, Vol 41, Num 6, pp 1322-1323, issn 0125-1562, 2 p.Article

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?THERON, Grant; PETER, Jonny; DOWDY, David et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 6, pp 527-532, issn 1473-3099, 6 p.Article

Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of staySCARSI, Kimberly K; FEINGLASS, Joe M; SCHEETZ, Marc H et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 10, pp 3355-3360, issn 0066-4804, 6 p.Article

Where do we go from here?PIZZO, Philip A.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, issn 0305-7453, i16-i17, SUP1Article

Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients : a meta-analysis of randomised controlled trialsVARDAKAS, Konstantinos Z; SAMONIS, George; CHRYSANTHOPOULOU, Stauroula A et al.Lancet. Infectious diseases (print). 2005, Vol 5, Num 7, pp 431-439, issn 1473-3099, 9 p.Article

Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort studyBRAYKOV, Nikolay P; MORGAN, Daniel J; PERENCEVICH, Eli et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 12, pp 1220-1227, issn 1473-3099, 8 p.Article

Impact sur la fonction rénale d'un relais précoce de la formulation conventionnelle de l'amphotéricine B par sa formulation liposomale dans le cadre d'un traitement empirique antifongique (Étude Nephemat) = Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infectionsISNARD, F; TILLEUL, P; LAPORTE, J.-P et al.Médecine et maladies infectieuses. 2008, Vol 38, Num 4, pp 208-214, issn 0399-077X, 7 p.Article

Place du méropénème dans la prise en charge des neutropénies fébriles = Meropenem for the management of patients with febrile neutropeniaMILPIED, N.La Lettre de l'infectiologue. 2008, Vol 23, Num 1, pp 27-31, issn 0296-9009, 5 p., SUPArticle

Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based AnalysisRETAMAR, Pilar; PORTILLO, Maria M; TORRES-TORTOSA, Manuel et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 1, pp 472-478, issn 0066-4804, 7 p.Article

Constructing Unit-Specific Empiric Treatment Guidelines for Catheter-Related and Primary Bacteremia by Determining the Likelihood of Inadequate TherapyDAVIS, Megan E; ANDERSON, Deverick J; SHARPE, Michelle et al.Infection control and hospital epidemiology. 2012, Vol 33, Num 4, pp 416-420, issn 0899-823X, 5 p.Article

Diagnostic Testing or Empirical Therapy for Patients Hospitalized with Suspected Influenza : What to Do?MCGEER, Allison J.Clinical infectious diseases. 2009, Vol 48, issn 1058-4838, S14-S19, SUP1Article

Etiology of infection, empirical treatment and prophylaxisELTAHAWY, Ahmed T.Saudi medical journal. 2003, Vol 24, Num 4, pp 331-336, issn 0379-5284, 6 p.Article

Impact of Antibiotic Resistance in Gram-Negative Bacilli on Empirical and Definitive Antibiotic TherapyPATERSON, David L.Clinical infectious diseases. 2008, Vol 47, issn 1058-4838, S14-S20, SUP1Article

Invasive Candida species infection : the importance of adequate empirical antifungal therapyARMSTRONG-JAMES, Darius.Journal of antimicrobial chemotherapy (Print). 2007, Vol 60, Num 3, pp 459-460, issn 0305-7453, 2 p.Article

Prophylactic and Empiric Use of Antibiotics in Dermatologic Surgery: A Review of the Literature and Practical ConsiderationsROSSI, Anthony M; MARIWALLA, Kavita.Dermatologic surgery. 2012, Vol 38, Num 12, pp 1898-1921, issn 1076-0512, 24 p.Article

Present situation in the treatment of invasive fungal infectionDE PAUW, Ben E; PICAZO, Juan J.International journal of antimicrobial agents (Print). 2008, Vol 32, issn 0924-8579, s167-s171, SUP2Conference Paper

Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?DE VRIES, M. G; EKKELENKAMP, M. B; PETERS, E. J. G et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 3, pp 453-456, issn 0934-9723, 4 p.Article

Gram-negative bacteremia: Which empirical antibiotic therapy?SHOAI TEHRANI, M; HAJAGE, D; NHAN, T. X et al.Médecine et maladies infectieuses. 2014, Vol 44, Num 4, pp 159-166, issn 0399-077X, 8 p.Article

Appropriateness of Empirical Treatment and Outcome in Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing BacteriaFRAKKING, Floririe N. J; ROTTIER, Wouter C; VLAMINCKX, Bart J. M et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3092-3099, issn 0066-4804, 8 p.Article

Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniaeKANG, Cheol-In; SO YEON PARK; DOO RYEON CHUNG et al.The Journal of infection. 2012, Vol 64, Num 5, pp 533-534, issn 0163-4453, 2 p.Article

Empiric Antifungal Therapy and Outcomes in Extremely Low Birth Weight Infants with Invasive CandidiasisGREENBERG, Rachel G; BENJAMIN, Daniel K; MILLER, Nancy A et al.The Journal of pediatrics. 2012, Vol 161, Num 2, pp 264-269, issn 0022-3476, 6 p.Article

Empirical Medical Therapy for Idiopathic Male Infertility: A Survey of the American Urological AssociationKO, Edmund Y; SIDDIQI, Kashif; BRANNIGAN, Robert E et al.The Journal of urology. 2012, Vol 187, Num 3, pp 973-978, issn 0022-5347, 6 p.Article

Evaluation of empirical antibiotherapy for acute community-acquired pneumonia prescribed in emergency departmentsFRAISSE, T; FAYAD, G; JARDY, C et al.Médecine et maladies infectieuses. 2012, Vol 42, Num 1, pp 5-9, issn 0399-077X, 5 p.Article

Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief reportNGAI, Angela L; BOURQUE, Michael R; LUPINACCI, Robert J et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 6, pp 540-544, issn 0924-8579, 5 p.Article